Literature DB >> 3263453

Results of a rigorous follow-up system in colorectal cancer.

E Wenzl1, M Wunderlich, F Herbst, M Schemper, W Feil, R Rauhs, R Schiessel.   

Abstract

Results of a computer-aided follow-up programme for patients with colorectal cancer are analyzed. Between 1978 and 1987 1293 patients underwent this programme, the drop-out rate was 17%. 299 recurrences in 168 patients were discovered (40% local recurrence, 29% liver metastases and 31% others). Fifty-one per cent of patients with local recurrence and 47% with liver metastases were symptom free. Radical surgery could be performed in 50% of local recurrences and in 26% of liver metastases. The three year survival rate after radical surgery for recurrence was 35% for local recurrences and 33% for liver metastases, the five-year-survival rate 23% and 15%, respectively.

Entities:  

Mesh:

Year:  1988        PMID: 3263453     DOI: 10.1007/bf01648363

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  8 in total

1.  [Recurrence of rectal cancer (author's transl)].

Authors:  R Winkler
Journal:  Langenbecks Arch Chir       Date:  1975-06-09

2.  Value of a follow-up study of recurrent carcinoma of the colon and rectum.

Authors:  C A Ekman; J Gustavson; A Henning
Journal:  Surg Gynecol Obstet       Date:  1977-12

3.  [Local recurrences following carcinoma of the rectum-etiology, diagnosis, prognosis (author's transl)].

Authors:  P Hermanek; F P Gall; A Altendorf
Journal:  Langenbecks Arch Chir       Date:  1982

4.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

5.  Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy.

Authors:  J G Fortner; J S Silva; E B Cox; R B Golbey; H Gallowitz; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

6.  [Value of computer tomography of the small pelvis for the early diagnosis of local recurrence after surgery of rectal cancer].

Authors:  M Wunderlich; R Schiessel; E Kovats; R Rauhs; W Seidl; H Imhof; P Hajek
Journal:  Wien Klin Wochenschr       Date:  1983-04-29       Impact factor: 1.704

7.  Local recurrence of colorectal cancer: effect of early detection and aggressive surgery.

Authors:  R Schiessel; M Wunderlich; F Herbst
Journal:  Br J Surg       Date:  1986-05       Impact factor: 6.939

8.  CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.

Authors:  E W Martin; J P Minton; L C Carey
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

  8 in total
  4 in total

1.  Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer.

Authors:  R Bergamaschi; J P Arnaud
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

2.  Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence.

Authors:  Chin-Hsin Chen; Mon-Chau Hsieh; Cheng-Chou Lai; Chien-Yuh Yeh; Jinn-Shiun Chen; Pao-Shiu Hsieh; Jy-Ming Chiang; Wen-Sy Tsai; Reiping Tang; Chung-Rong Changchien; Jeng-Yi Wang
Journal:  Int J Colorectal Dis       Date:  2010-02-17       Impact factor: 2.571

3.  Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.

Authors:  Hartwig Körner; Kjetil Söreide; Pål J Stokkeland; Jon Arne Söreide
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

4.  Follow-up of patients with colorectal cancer. A meta-analysis.

Authors:  D J Bruinvels; A M Stiggelbout; J Kievit; H C van Houwelingen; J D Habbema; C J van de Velde
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.